跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ISTURISA 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ISTURISA 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ISTURISA 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Recordati Rare Diseases
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 12, 2021
Approval ID
6ad952a41c5ff5bc
Company
Recordati Rare Diseases
Type
Standard
Approval Details
Approval Id
6ad952a41c5ff5bc
Drug Cima Aemps Name
ISTURISA 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1171409002
Holder Company Name
Recordati Rare Diseases
Marketing Company Name
Recordati Rare Diseases Spain, S.L.U.
Holder Company Detail Path
/organization/recordati-rare-diseases
Authorization Date
2021-02-12
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Recordati Rare Diseases
Company Detail Path
/organization/recordati-rare-diseases
Company Information
Pharmaceutical Company Name
RECORDATI RARE DISEASES
Country Name
France
City Name
puteaux,ile de france,country_fr
Address
IMMEUBLE LE WILSON IMM LE WILSON 1
Website
https://www.recordatirarediseases.com
Active Ingredients
OSILODROSTAT FOSFATO
7,155 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 12, 2021
Approval ID
6ad952a41c5ff5bc
Type
Standard
Back to CIMA-AEMPS Approvals
